A Single-Dose Study to Evaluate the Pharmacokinetic, Safety, Tolerability Profile and the Effects of Food on the Pharmacokinetics of Different Formulations of Cariprazine in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 09 May 2019
Price : $35 *
At a glance
- Drugs Cariprazine (Primary)
- Indications Bipolar depression; Bipolar disorders; Major depressive disorder; Schizophrenia
- Focus Pharmacokinetics
- Sponsors Gedeon Richter
- 23 Mar 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Dec 2015 Planned number of patients changed from 200 to 160 as reported by ClinicalTrials.gov.
- 09 Dec 2015 Planned End Date changed from 1 Jan 2016 to 1 Feb 2016 as reported by ClinicalTrials.gov.